Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katharine Mckinley Esselen, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gompers A, Larson E, Esselen KM, Farid H, Dodge LE. Financial toxicity in pregnancy and postpartum. Birth. 2023 Feb 19. PMID: 36807551.
    Citations:    Fields:    
  2. Liang MI, Harrison R, Aviki EM, Esselen KM, Nitecki R, Meyer L. Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens. Gynecol Oncol. 2023 03; 170:317-327. PMID: 36758422.
    Citations:    Fields:    
  3. Abt D, Macharia A, Hacker MR, Baig R, Esselen KM, Ducie J. Endometrial stripe thickness: a preoperative marker to identify patients with endometrial intraepithelial neoplasia who may benefit from sentinel lymph node mapping and biopsy. Int J Gynecol Cancer. 2022 Jul 22. PMID: 35868657.
    Citations: 1     Fields:    
  4. Hecht JL, Janikova M, Choudhury R, Liu F, Canesin G, Janovicova L, Csizmadia E, Jorgensen EM, Esselen KM, Celec P, Swanson KD, Wegiel B. Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer. Cancers (Basel). 2022 Apr 29; 14(9). PMID: 35565370; PMCID: PMC9105072.
    Citations:    
  5. Le PT, Ha N, Tran NK, Newman AG, Esselen KM, Dalrymple JL, Schmelz EM, Bhandoola A, Xue HH, Singh PB, Thai TH. Targeting Cbx3/HP1? Induces LEF-1 and IL-21R to Promote Tumor-Infiltrating CD8 T-Cell Persistence. Front Immunol. 2021; 12:738958. PMID: 34721405.
    Citations:    Fields:    Translation:AnimalsCells
  6. Luckett R, Painter H, Hacker MR, Simon B, Seiphetlheng A, Erlinger A, Eakin C, Moyo S, Kyokunda LT, Esselen K, Feldman S, Morroni C, Ramogola-Masire D. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study. BJOG. 2021 11; 128(12):1986-1996. PMID: 34008294; PMCID: PMC8497414.
    Citations: 3     Fields:    Translation:HumansCells
  7. Esselen KM, Gompers A, Hacker MR, Bouberhan S, Shea M, Summerlin SS, Rucker LR, Huh WK, Pisu M, Liang MI. Evaluating meaningful levels of financial toxicity in gynecologic cancers. Int J Gynecol Cancer. 2021 06; 31(6):801-806. PMID: 33858954.
    Citations: 10     Fields:    Translation:Humans
  8. Esselen KM, Stack-Dunnbier H, Gompers A, Hacker MR. Crowdsourcing to measure financial toxicity in gynecologic oncology. Gynecol Oncol. 2021 05; 161(2):595-600. PMID: 33551197; PMCID: PMC10029746.
    Citations: 7     Fields:    Translation:Humans
  9. O'Connor SK, Ryley DA, Obasiolu CW, Esselen KM, Skiadas CC, Kuohung W. Vaginal cuff dehiscence following transvaginal oocyte retrieval: a case report. Fertil Res Pract. 2020; 6:16. PMID: 32905306; PMCID: PMC7469333.
    Citations: 1     
  10. Esselen K, Sinno AK, Varughese J, Wethington SL, Prendergast E, Chu CS. Social needs in gynecologic oncology: A Society of Gynecologic Oncology (SGO) clinical practice statement. Gynecol Oncol. 2020 09; 158(3):521-525. PMID: 32694062.
    Citations: 2     Fields:    Translation:Humans
  11. Lee EK, Esselen KM, Kolin DL, Lee LJ, Matulonis UA, Konstantinopoulos PA. Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type. JCO Precis Oncol. 2020; 4:736-742. PMID: 32704608.
    Citations: 4     Fields:    
  12. Connor YD, Miao D, Lin DI, Hayne C, Howitt BE, Dalrymple JL, DeLeonardis KR, Hacker MR, Esselen KM, Shea M. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts. Gynecol Oncol. 2020 04; 157(1):106-114. PMID: 31954538.
    Citations: 11     Fields:    Translation:Humans
  13. Ore AS, Shear MA, Liu FW, Dalrymple JL, Awtrey CS, Garrett L, Stack-Dunnbier H, Hacker MR, Esselen KM. Adoption of enhanced recovery after laparotomy in gynecologic oncology. Int J Gynecol Cancer. 2020 01; 30(1):122-127. PMID: 31771963; PMCID: PMC8939246.
    Citations: 4     Fields:    Translation:Humans
  14. Luckett R, Mogowa N, Li HJ, Erlinger A, Hacker MR, Esselen K, Feldman S, Shapiro R, Morroni C, Ramogola-Masire D. Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus. Obstet Gynecol. 2019 10; 134(4):840-849. PMID: 31503167; PMCID: PMC6768725.
    Citations: 8     Fields:    Translation:HumansCells
  15. Bouberhan S, Shea M, Kennedy A, Erlinger A, Stack-Dunnbier H, Buss MK, Moss L, Nolan K, Awtrey C, Dalrymple JL, Garrett L, Liu FW, Hacker MR, Esselen KM. Financial toxicity in gynecologic oncology. Gynecol Oncol. 2019 07; 154(1):8-12. PMID: 31053404; PMCID: PMC7001853.
    Citations: 25     Fields:    Translation:Humans
  16. Franconeri A, Boos J, Fang J, Shenoy-Bhangle A, Perillo M, Wei CJ, Garrett L, Esselen K, Fong L, Brook OR. Adnexal mass staging CT with a disease-specific structured report compared to simple structured report. Eur Radiol. 2019 Sep; 29(9):4851-4860. PMID: 30820722.
    Citations: 2     Fields:    Translation:Humans
  17. Luckett R, Kalenga K, Liu F, Esselen K, Awtrey C, Mmalane M, Moloi T, Ricciotti H, Grover S. Pilot of an International Collaboration to Build Capacity to Provide Gynecologic Oncology Surgery in Botswana. Int J Gynecol Cancer. 2018 11; 28(9):1807-1811. PMID: 30308556; PMCID: PMC6221384.
    Citations: 4     Fields:    Translation:Humans
  18. Lightfoot MDS, Esselen KM, Haviland MJ, Dalrymple JL, Awtrey CS, Garrett LA, Hacker MR, Liu FW. Participation in global health delivery: Survey results from the Society of Gynecologic Oncology. Gynecol Oncol Rep. 2018 Nov; 26:7-10. PMID: 30140725; PMCID: PMC6104590.
    Citations: 1     
  19. Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AA. Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncol. 2016 Nov 01; 2(11):1427-1433. PMID: 27442965; PMCID: PMC5106306.
    Citations: 19     Fields:    Translation:Humans
  20. Esselen KM, Terry KL, Samuel A, Elias KM, Davis M, Welch WR, Muto MG, Ng SW, Berkowitz RS. Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery? Gynecol Oncol. 2016 08; 142(2):255-60. PMID: 27261327.
    Citations: 10     Fields:    Translation:Humans
  21. Hinchcliff EM, Esselen KM, Watkins JC, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma. J Minim Invasive Gynecol. 2016 May-Jun; 23(4):567-72. PMID: 26851414.
    Citations: 13     Fields:    Translation:Humans
  22. Strickland KC, Nucci MR, Esselen KM, Muto MG, Chopra S, George S, Howitt BE. Solitary Fibrous Tumor of the Uterus Presenting With Lung Metastases: A Case Report. Int J Gynecol Pathol. 2016 Jan; 35(1):25-9. PMID: 26107564.
    Citations: 4     Fields:    Translation:Humans
  23. Esselen KM, Vitonis A, Einarsson J, Muto MG, Cohen S. Health Care Disparities in Hysterectomy for Gynecologic Cancers: Data From the 2012 National Inpatient Sample. Obstet Gynecol. 2015 Nov; 126(5):1029-1039. PMID: 26444112.
    Citations: 5     Fields:    Translation:Humans
  24. Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF. Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. Int J Cancer. 2015 Aug 15; 137(4):776-83. PMID: 25626421.
    Citations: 24     Fields:    Translation:HumansCells
  25. Aviki EM, Esselen KM, Barcia SM, Nucci MR, Horowitz NS, Feltmate CM, Berkowitz RS, Orgill DG, Viswanathan AN, Muto MG. Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? Gynecol Oncol. 2015 Apr; 137(1):60-5. PMID: 25667974.
    Citations: 4     Fields:    Translation:Humans
  26. Vargas R, Barroilhet LM, Esselen K, Diver E, Bernstein M, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med. 2014 May-Jun; 59(5-6):188-94. PMID: 24937955.
    Citations: 12     Fields:    Translation:Humans
  27. Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS. What is the optimal treatment for obese patients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014 Sep; 211(3):231.e1-9. PMID: 24704062.
    Citations: 5     Fields:    Translation:Humans
  28. Esselen KM, Ng SK, Hua Y, White M, Jimenez CA, Welch WR, Drapkin R, Berkowitz RS, Ng SW. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens. Gynecol Oncol. 2014 Feb; 132(2):316-21. PMID: 24333360.
    Citations: 7     Fields:    Translation:HumansCells
  29. Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Sep; 23(7):1219-25. PMID: 23975042.
    Citations: 3     Fields:    Translation:Humans
  30. Esselen KM, Feldman S. Cost-effectiveness of cervical cancer prevention. Clin Obstet Gynecol. 2013 Mar; 56(1):55-64. PMID: 23318570.
    Citations: 3     Fields:    Translation:Humans
  31. Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy. Gynecol Oncol. 2012 Oct; 127(1):51-4. PMID: 22659193.
    Citations: 8     Fields:    Translation:Humans
  32. Esselen KM, Boruta DM, del Carmen M, Schorge JO, Goodman A, Growdon WB. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review. Int J Gynecol Cancer. 2011 Aug; 21(6):1078-83. PMID: 21633304.
    Citations: 7     Fields:    Translation:Humans
  33. Esselen KM, Rodriguez N, Horowitz NS, Campos SM. Patterns of recurrence in advanced epithelial ovarian, fallopian tube, and peritoneal cancers treated with intraperitoneal chemotherapy. J Clin Oncol. 2011 May 20; 29(15_suppl):5072. PMID: 28023665.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Esselen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (156)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.